Verseau Therapeutics

1 follower


Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors.

Industries

Employees

11-50

Links


Org chart

Tatiana Novobrantseva
Co-Founder & Chief Scientific Officer
Lou Vaickus
Chief Medical Officer
Susan Low
Vice President

Board & advisors

Daniel Anderson
Board Member
Jong Chang
Board Member
Wen Chen
Board Member
Robert Langer
Board Member
Anna Turetsky
Board Member
Seung Min Yang
Board Member
Zhenping Zhu
Board Member